Discover 1,191 paid clinical trials in Nashville, Tennessee. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Nashville offers many research opportunities for conditions such as diabetes, cardiovascular disease, and arthritis, giving participants access to innovative treatments and cutting-edge medical care. The city’s leading healthcare institutions are actively recruiting healthy volunteers for paid research studies, as well as individuals seeking trials for specific health concerns.
Filter
2
Filter results
Results: 1,191
Active & Responsive
A Study to Evaluate the Safety and Efficacy of Gocatamig (MK-6070) and Ifinatamab Deruxtecan (I-DXd) in Participants With Relapsed/Refractory Extensive-Stage Small Cell Lung Cancer (MK-6070-002)
for
Small Cell Lung Cancer
Location: Nashville TN, Chicago IL, Buffalo NY, Hackensack NJ,
Sponsor: Merck Sharp & Dohme LLC
Sex: All
Age: 18+
Code: NCT06780137
Phase1, Phase2, Recruiting
Active & Responsive
Child to Adult Neurodevelopment in Gene Expanded Huntington's Disease
for
Huntington's Disease
Location: Nashville TN, Iowa City IA, Houston TX, Philadelphia PA,
Sponsor: Peggy C Nopoulos
Sex: All
Age: 6 - 30
Code: NCT01860339
Recruiting
Active & Responsive
Clinical Study of Antibody-Drug Conjugate MYTX-011 in Subjects With Non-Small Cell Lung Cancer
for
NSCLC, NSCLC Stage IV, NSCLC Stage IIIB,
Location: Nashville TN, Atlanta GA, St Louis MO, Charleston SC,
Sponsor: Mythic Therapeutics
Sex: All
Age: 18+
Code: NCT05652868
Phase1, Recruiting
Active & Responsive
BradycArdia paCemaKer With AV Interval Modulation for Blood prEssure treAtmenT
Location: Nashville TN, Lexington KY, Germantown TN, Atlanta GA,
Sponsor: Orchestra BioMed, Inc
Sex: All
Age: 18+
Code: NCT06059638
Recruiting
Active & Responsive
Study of INBRX-106 and INBRX-106 in Combination With Pembrolizumab (Keytruda®) in Subjects With Locally Advanced or Metastatic Solid Tumors (Hexavalent OX40 Agonist)
for
Solid Tumor, Non-Small Cell Lung Cancer, Head and Neck Cancer,
Location: Nashville TN, Louisville KY, Atlanta GA, Chicago IL,
Sponsor: Inhibrx Biosciences, Inc
Sex: All
Age: 18+
Code: NCT04198766
Phase1, Phase2, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Active & Responsive
A Phase 1 Study of XL309 (ISM3091) Alone and in Combination in Participants With Advanced Solid Tumors